MDXR — MEDICAL EXERCISE INC. — Income statement
From the XBRL facts of the company's SEC filings. USD, millions, except per-share figures. Latest filing read: 2026-08-19.
Annual · Quarterly | Latest filing · As first reported | Download all statements (Excel)
| Mar 2025 | Mar 2026 | TTM Jun 2026 | |
|---|---|---|---|
| Revenues | 0.0 | - | - |
| Total revenues | 0.0 | - | - |
| Cost of revenues | 0.0 | - | - |
| Gross profit | 0.0 | - | - |
| Selling, general and administrative | 0.2 | - | - |
| Other operating expenses, total | 0.2‡ | 0.2‡ | 0.2‡ |
| Operating income (GAAP, as reported) | (0.3) | (0.2) | (0.2)‡ |
| Operating income excl. unusual items (S&P method) | (0.3)‡ | (0.2)‡ | - |
| Other non-operating income (expenses) | 0.0‡ | 0.0‡ | 0.0‡ |
| Asset writedown | 0.0‡ | - | - |
| Total unusual items | 0.0‡ | 0.0‡ | 0.0‡ |
| EBT excl. unusual items | (0.3)‡ | (0.2)‡ | (0.2)‡ |
| EBT incl. unusual items | (0.3) | (0.2) | (0.2)‡ |
| Earnings from continuing operations | (0.3) | - | - |
| Net income | (0.3) | (0.2) | (0.2)‡ |
| NI to common incl. extra items | (0.3)‡ | (0.2)‡ | (0.2)‡ |
| NI to common excl. extra items | (0.3)‡ | (0.2)‡ | (0.2)‡ |
| Revenue per share | 0.00‡ | - | - |
| Basic EPS | (0.03) | (0.02) | (0.02)‡ |
| Basic weighted average shares | 12.2 | 12.6 | 12.9‡ |
| Diluted EPS | (0.03) | (0.02) | (0.02)‡ |
| Diluted weighted average shares | 12.2 | 12.6 | 12.9‡ |
| Normalized net income (S&P method, 37.5 %) | (0.2)‡ | (0.1)‡ | (0.1)‡ |
| Normalized basic EPS (S&P method) | (0.02)‡ | (0.01)‡ | (0.01)‡ |
| Normalized diluted EPS (S&P method) | (0.02)‡ | (0.01)‡ | (0.01)‡ |
| EBITDA | (0.3)‡ | (0.2)‡ | (0.2)‡ |
| EBIT | (0.3)‡ | (0.2)‡ | (0.2)‡ |
‡ derived by arithmetic from reported figures (a fourth quarter is the year less nine months). † read from a substitute line. § reported in a note, not on the face of the statement. “-” not reported. NM not meaningful. Normalized rows follow the S&P method: pre-tax income excluding unusual items, a flat 37.5 % tax rate, less minority interest.